Accuray Incorporated (FRA:XEJ)

Market Cap	77.02M -65.7%
Revenue (ttm)	384.30M +1.5%
Net Income	-16.46M
EPS	-0.15
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	65
Open	0.6800
Previous Close	0.6700
Day's Range	0.6800 - 0.6800
52-Week Range	0.6700 - 2.5400
Beta	n/a
RSI	35.43
Earnings Date	Feb 4, 2026

About Accuray

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidne...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1990
• Employees: 990
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: XEJ

Financial Performance

In fiscal year 2025, Accuray's revenue was $458.51 million, an increase of 2.68% compared to the previous year's $446.55 million. Losses were -$1.59 million, -89.77% less than in 2024.

Financial numbers in USD